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Abstract: Cocultures of septal and hippocampal tissues taken from 
6- to 7-day-old rats were maintained in culture for up to 30 days in 
the presence and absence of nerve growth factor (NGF), and their 
Chol-1 contents determined at varying time intervals by a modified 
enzyme-linked immunosorption assay (ELISA). The major brain 
gangliosides were determined densitometrically after spraying chro- 
matograms with resorcinol reagent. There was little change in the 
contribution of the major gangliosides to the total ganglioside content 
of the explants either with time or the presence or absence of NGF, 
the only exception being an NGF-insensitive fall in the contribution 
of GM 1 to about 60% of its initial value at 20 and 30 days. By contrast, 
the concentration of Chol-1 expressed either per unit weight of gan- 
glioside sialic acid or protein increased considerably in culture and 
this increase was enhanced by NGF. The effect of NGF resembles 
that on other cholinergic markers, choline acetyltransferase and ace- 
tylcholinesterase, and may be attributed to an NGF-stimulated hip- 
pocampal ingrowth of cholinergic fibres and enhanced survival of 
cholinergic septal neurons. The Chol-1 concentration finally attained 
in the presence of NGF and the time course of its increase. parallel 
those. previously found in vivo and indicate the potential usefulness 
of septal-hippocampal cocultures for investigating the function of 
Chol- I.  Key Words: Septal-hippocampal cocultures-Expression of 
Chol-I-Nerve growth factor. Derrington E. A. et al. Nerve growth 
factor enhances the expression of the cholinergic-specific ganglioside 
Chol-1 in cocultures of rat septum and hippocampus. J.  Neurochem. 
55,2 132-2 134 ( 1990). 
Previous studies have shown that a group of gangliosidic 
antigens, collectively designated Chol- 1, and originally de- 
tected in the cholinergic electromotor innervation of the 
electric ray, Torpedo marmorata, are also present in the 
mammalian central and peripheral nervous systems, where 
they are specific for cholinergic neurons (Jones et al., 1981; 
Richardson et al., 1982; Ferretti and Borroni, 1986; Der- 
rington et al., 1989; Giuliani et al., 1990). These antigens are 
first detected relatively late in development in both the central 
and peripheral nervous systems (Derrington and Borroni, 
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1990), a result suggesting that their appearance represents a 
membrane modification related to the stabilization or survival 
of cholinergic synapses. Thus, in the rat hippocampus, Chol- 
1 is first detected between the 10th and 20th day ofpostnatal 
life, reaching its adult value at 50 days; by contrast, choline 
acetyltransferase (ChAT) first appears between 5 and 10 days 
and reaches its adult value at 30 days (Demngton and Bor- 
roni, 1990). 
Neurites of septal neurons have been shown to grow out 
and form cholinergic synapses with hippocampal cells when 
septal and hippocampal explants from neonatal rats are co- 
cultured in vitro. The expression of cholinergic function as 
measured by the appearance of ChAT is enhanced by the 
addition of nerve growth factor (NGF) to the culture medium 
(Gahwiler and Brown, 1987; Gahwiler et al., 1990). We 
wished to investigate (a) the time-course of expression of Chol- 
1 in the hippocampal explants in order to compare this with 
events in vivo, and (b) the response of Chol-1 to NGF. It was 
felt that if the Chol- 1 content of the explants were enhanced 
by NGF, the in vitro hippocampus could provide a useful 
tool for investigating the function of Chol- 1. 
MATERIALS AND METHODS 
Tissue culture 
Cocultures of  hippocampal and septal slices (Gahwiler, 
198 1) were prepared in Zurich from 5- to 6-day-old rats and 
grown in culture medium by means of the roller-tube tech- 
nique with or without NGF (100 ng/ml) for up to 30 days. 
The culture medium consisted of horse serum (25%), basal 
Eagle’s medium supplemented with Earle’s salt mixture 
(50%), and Earle’s balanced salt solution (25%), and was sup- 
plemented with glucose to a final concentration of 6.5 g/L. 
After 10, 20, or 30 days cultures were fixed for 1 h in 4% 
paraformaldehyde and after washing in phosphate-buffered 
Abbreviations used: ChAT, choline acetyltransferase; ELISA, en- 
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saline mailed to Gottingen for ganglioside analysis. Cultures 
were scraped from the coverslips on which they were grown 
into 1.2 ml-capacity Eppendorf centrifuge tubes using a dis- 
section microscope. The tissue was pelleted by centrifugation 
at 10,000 g for 5 rnin and the supernatant decanted. An Ep- 
pendorf table-top centrifuge was used throughout. The pellets 
were frozen in liquid nitrogen and lyophilized. 
Analyses 
Extraction of gangliosides. Gangliosides were extracted 
from the lyophilized pellets by the method of Tettamanti et 
al. (1973), modified for very small (10 mg or less) tissue sam- 
ples. Potassium phosphate buffer (10 mM, pH 6.8) (100 pl) 
and tetrahydrofuran (400 pl) were added to an Eppendorf 
tube containing lyophilized tissue. The tissue was suspended 
by shaking for 30 s in a vortex mixer and then sonicated for 
2 rnin at room temperature with a Branson B 15 probe sonifier 
equipped with a standard microprobe at a frequency of 20 
kHz and a power setting of 2-3. Insoluble material was pel- 
leted by centrifugation for 10 rnin at 10,000 g and the su- 
pernatant transferred to a 2-ml-capacity Eppendorf tube. This 
extraction procedure was repeated three times. Diethyl ether 
(30% of the total supernatant volume) was added to the pooled 
supernatants, the whole was shaken for 2 rnin in a vortex 
mixer and then centrifuged at 10,000 g for 10 rnin to promote 
the separation of the phases. The aqueous (lower) phase was 
removed using a Pasteur pipette and stored. A second ex- 
traction of the ether phase was performed as described above 
after adding water (10% by volume) and shaking again for 2 
rnin in a vortex shaker. The two aqueous phases were pooled 
and the ether removed by evaporation in a stream of nitrogen 
gas. When organic solvents were no longer detectable by smell, 
the contents of the tubes were diaiysed for 16 h against distilled 
water (5 L, 2 changes). 
The dialysed ganglioside fractions were lyophilized and 
gangliosides solubilized in 200 pl of chloroform/methanol/ 
H 2 0  mixture in the ratio 100:50:10 by volume. 
Chol-I. The concentration of Chol- 1 present in ganglioside 
fractions was determined by means of a modified enzyme- 
linked immunosorption assay (ELISA) (Demngton and Bor- 
roni, 1990) which involved applying anti-Chol- 1 antiserum, 
enzyme-linked second antibody and enzyme substrate directly 
to TLC plates and evaluating the colour intensities densito- 
metrically. A commercial polysialoganglioside fraction, en- 
riched -40-fold in Chol- 1 relative to whole brain gangliosides 
(Dr. Pallmann KG, Munich, F.R.G.) and containing it in 
about 1% concentration, served as a standard. One unit of 
Chol-1 was defined as the amount in 100 ng of the fraction. 
Sialic acid. Ganglioside-bound sialic acid was assayed by 
the method of Svennerholm (1 957). 
Other gangliosides. In one experiment, the relative con- 
centrations of the major brain gangliosides were determined 
after separation by TLC and spraying with a resorcinol re- 
agent (Demngton and Borroni, 1990). The linearity of the 
chemical staining was established using various concentra- 
tions of a standard preparation of rat brain gangliosides. The 
identity of the various gangliosides was determined by com- 
paring their Rf values with those of pure samples of GM 1, 
GD la, GD1 b, and GT 1 b (kindly provided by Dr A. Giuliani, 
University of Milan, Italy). 
Protein analysis. The tissue pellets remaining from the 
ganglioside extraction were dried in a nitrogen stream, dis- 
solved in 0.1 M NaOH, and their protein content determined 
using the bicucculine method (Pierce). Though this proce- 
dure suffered from the problem that some lipophilic proteins 
would have been extracted with the gangliosides, it was im- 
possible to take a homogeneous sample for protein estimation 
at an earlier stage because the tissue had been fixed in para- 
formaldehyde. 
RESULTS 
Table 1 shows that cultures grown in the presence of NGF 
and those in its absence both show a slight increase in sialic 
acid per milligram of protein during the period in culture. 
This increase is slightly greater in NGF-treated cultures than 
controls. There is very little change in the relative contribution 
of the major gangliosides to the total ganglioside content of 
the explants either with time or the presence or absence of 
NGF. The only relatively large change occurs in the concen- 
tration of GM 1 which falls from 14 and 15% in treated and 
control cultures, respectively, to 9% of the total mixture at 
20 and 30 days. By contrast, the concentration of Chol-1 
expressed per microgram of ganglioside sialic acid (Table 1, 
last column) or per milligram of protein (Fig. 1) shows a 
considerable increase during development in culture. Ex- 
pressed per microgram of sialic acid (Table l), it nearly dou- 
bles in controls and rises more than 300% in cultures treated 
with NGF. This 300% increase is similar to that shown by 
Chol-1 in the hippocampus during a similar period of de- 
velopment in vivo (Derrington and Borroni, 1990). Expressed 
per milligram of protein (Fig. l), the effect of NGF is even 
greater (400% at 30 days), greatly outstripping that of the 
major gangliosides over the same period (40% in NGF-treated 
cultures and 20% in controls). 
TABLE 1. Effect of NGF on explant ganglioside content and distribution 
Distribution of sialic acid among major 
Time in gangliosides (%) 
culture Ganglioside sialic acid Chol-1 content 
(days) NGF" (pg/mg of protein)* GM I GDla GDlb GTlb (U/pg of sialic acid)* 
~ ~~~~ 
5.0 f 0.4 15 37 19 28 1.33 f 0.44 10 + 4.7 f 0.1 14 41 17 28 1.34 f 0.52 
20 - 5.6 f 1.5 9 37 23 31 1.71 -C 0.19 
+ 7.1 -C 0.2 9 34 24 33 2.37 k 0.46 
30 - 5.9 f 0.2 9 38 21 32 2.54 f 0.73 
+ 6.7 f 0.3 9 37 22 32 4.08 f 0.73 
- 
For definition of unit of Chol- 1, see text. 
a NGF present (+); NGF absent (-). ' Data are mean k SD values of three experiments. 
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FIG. 1. Chol-1 content of explants (ordinate) plotted as a function 
of the time in culture (abscissa) and the effect of NGF on this. 
Open triangles, no supplement; filled triangles, supplemented with 
NGF; values are means f SD (bars) of three experiments. For 
definition of unit of Chol-1 see text. 
DISCUSSION 
In vivo, the expression of the Chol-1 gangliosides in the 
hippocampus is a n  event which occurs late during synapto- 
genesis. Quantitative analysis has shown that it parallels the 
increase in expression of ChAT though lagging behind the 
latter by about 10 days (Derrington and Borroni, 1990). This 
result was interpreted to mean that the expression of Chol- 
1 is an event occurring late in synaptogenesis. Similarly, in 
culture Chol-l is expressed after the other major gangliosides, 
and the concentration of Chol-1 per milligram of protein 
increases much more rapidly than that of the major brain 
gangliosides at this late stage in development. Treatment of 
the cultures with NGF, which is known to be important both 
for the stimulation of cholinergic differentiation and as a sur- 
vival factor for cholinergic neurons (Gahwiler and Brown, 
1987; Gahwiler et al., 1990), exacerbates the increases in 
concentration of Chol-1 per milligram of protein to  rates of 
increase which are similar to  those which occur in the hip- 
pocampus during development in vivo. Thus, the effect of 
NGF resembles that on other cholinergic markers, ChAT 
and acetylcholinesterase, as seen after four weeks in vitro 
(Gahwiler et al., 1990), and may be attributed to an NGF- 
stimulated hippocampal ingrowth of cholinergic fibres and 
enhanced survival of cholinergic septal neurons. Unfortu- 
nately, the present study does not allow us to decide whether 
the effect of N G F  is the result of an increase in the total 
number of cholinergic terminals present in the cultures or in 
the quantity of Chol- 1 in each terminal. Nevertheless, it ap- 
pears that the cocultures of septal and hippocampal brain 
slices provide a promising model system in which to inves- 
tigate the function of Chol- I. 
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